FDG-PET in a case of multiple bone metastases of gastric cancer

被引:0
作者
Takako Nakai
Chio Okuyama
Takao Kubota
Yo Ushuima
Tsunehiko Nishimura
机构
[1] Kyoto Prefectural University of Medicine,Department of Radiology
来源
Annals of Nuclear Medicine | 2005年 / 19卷
关键词
FDG-PET; Tc-99m HMDP bone scintigraphy; bone metastasis;
D O I
暂无
中图分类号
学科分类号
摘要
F-18 2-fluoro-2-deoxy-d-glucose (FDG) positron emission tomography (PET) is useful for surveys to detect bone metastasis because of its greater specificity than bone scintigraphy. However, FDG-PET is also known to yield false-positive results in acute fractures and inflammatory lesions, and distinguishing between benign and malignant lesions is difficult, even when semiquantitative methods are used. We report a case of multiple bone metastases of gastric cancer. One of the bone lesions that was positive for FDG uptake was benign, suggesting that FDG-PET can yield false-positive results.
引用
收藏
页码:51 / 54
页数:3
相关论文
共 38 条
[1]  
Bury T(1998)Fluorine-18 deoxyglucose positron emission tomography for the detection of bone metastases in patients with non-small cell lung cancer Eur J Nucl Med 25 1244-1247
[2]  
Barreto A(1997)Value of Anticancer Res 17 1687-1692
[3]  
Daenen F(2001)fluoro-deoxyglucose positron emission tomography in the staging of recurrent breast carcinoma Nucl Med Commun 22 875-879
[4]  
Barthelemy N(1996)Whole body PET for the evaluation of bony metastases in patients with breast cancer: comparison with Radiology 199 751-756
[5]  
Ghaye B(1998)Tc J Clin Oncol 16 3375-3379
[6]  
Rigo P(2003)-MDP bone scintigraphy Clin Nucl Med 28 302-307
[7]  
Bender H(2003)Metastatic prostate cancer: initial findings of PET with 2-deoxy-2-[F-18]fluoro- Clin Nucl Med 28 171-175
[8]  
Kirst J(2004)-glucose Skeletal Radiol 33 99-101
[9]  
Palmedo H(2003)Detection of bone metastases in breast cancer by Clin Nucl Med 28 668-669
[10]  
Schomburg A(undefined)FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions undefined undefined undefined-undefined